Peter Schoenmakers has been named “Knight of the Order of the Netherlands Lion” in a ceremony on 28 June 2022. The honour was bestowed for his exceptional achievements in the field of analytical chemistry, all of which have earned him international recognition and acclaim.
This royal commendation is one of the oldest and highest civil honours in the Netherlands. King Willem I established the order on 29 September 1815. Candidates who have made an exceptional contribution to society, especially in science, art, sports, and literature, are eligible for this honour. The decoration was presented to Peter by Annette Groot, Deputy Mayor of the Municipality of “Dijk en Waard”, after his valedictory speech marking his emeritus status as a professor of “Analytical Chemistry and its applications in Forensic Science”.
Anybody familiar with the field of chromatography will be aware of Peter’s achievements and contributions, especially towards the development of comprehensive two-dimensional liquid chromatography (LC×LC) and comprehensive two‑dimensional gas chromatography (GC×GC). His most recent work has focused on the concept of spatial three-dimensional liquid chromatography for the separation of a million components, the aptly named “A Million Peaks” project (also known as “Separation Technology for A Million Peaks” [STAMP]), which earned him the prestigious ERC Advanced Grant in 2016 worth around €2.5 million in funding.
Peter’s influence within the field of chromatography has led to numerous awards including: the Dal Nogare Award (2019) and the Csaba Horváth Memorial Award (2015). In August he will be presented with the 2022 Award in Chromatography by the American Chemical Society in Chicago, USA. He has (co-)authored more than 230 scientific publications in leading journals and supervised the research of 36 PhD students. He is also an editor for the Journal of Chromatography A and a member of LCGC’s editorial advisory board.
As a professor, Peter has led the analytical chemistry team in Amsterdam towards national recognition as a centre of expertise for analytical sciences in the Netherlands. He maintains a very extensive network of international, industrial, and academic contacts that he uses to further develop analytical chemistry in the Netherlands, which is evidenced by his role as one of the instigators of COAST, the public-private Community of Innovation in Analytical Science and Technology in the Netherlands. As its education director, he has created programmes to stimulate analytical science studies, with support for education amounting to more than €300,000 annually.
LCGC would like to extend its congratulations to Peter on this tremendous achievement.
Pittcon 2025: Xiao Su Discusses His Work in Electrochemical Separations
March 13th 2025In this video interview with Xiao Su, he dives deeper into the research that he and his team are conducting with redox-active polymers and the applicability of electrochemical approaches in separation science.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pittcon 2025: Kate Perrault Uptmor Talks About Multidimensional GC and Mentorship
March 13th 2025In our interview with Kate Perrault Uptmor, we asked her about the resources available for those interested in learning more about multidimensional chromatography, and current trends happening in separation science that are of particular note.
Analyzing Effects of Adverse Cardiovascular Events on Chronic Kidney Disease with HPLC
March 13th 2025Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse cardiovascular outcomes in individuals with chronic kidney disease (CKD). Plasma sphingosine-1-phosphate (S1P) levels were measured by high performance liquid chromatography (HPLC).